Sonire Therapeutics: Funding, Investors & Team (Oct 2026)
SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a novel therapeutic modality with the goal of giving cancer patients and their families a new future.
Sonire Therapeutics has raised $31.0M across 2 funding rounds on record, the most recent an undisclosed round of $13.0M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sonire Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Sonire Therapeutics Funding Rounds
Sonire Therapeutics raised $18.0M in a Series A announced in Apr 2026.
2 months later, an undisclosed round of $13.0M was announced in Jun 2026.
Sonire Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Sonire Therapeutics Funding Compared to Other Biotechnology Startups
Sonire Therapeutics' latest round of $13.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sonire Therapeutics in Biotechnology and Shinjuku
Companies Similar to Sonire Therapeutics
Arrowsmith is committed to unlocking the full potential of bacteriophages to revolutionize the treatment of…
LIFESCAPES is a researcher and manufacturer of brain-computer interface equipment. LIFESCAPES aims to use BMI…
Dioseve is providing novel possibilities for all life.
The GoldenHarvest vision is an ecosystem focused on the life operation that represents a new relationship…
Scohia Pharma is a biotech venture that will have both substantial research and development resources and be…
Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical…
Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on…
Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis…
Think Nature is a researcher startup that specializes in the solutions related to the sustainability of…
Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.
M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Sonire Therapeutics Funding FAQs
What does Sonire Therapeutics do?
SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a novel therapeutic modality with the goal of giving cancer patients and their families a new future.
How much funding has Sonire Therapeutics raised?
Sonire Therapeutics has raised $31.0M across 2 rounds on record. The most recent is an undisclosed round of $13.0M announced in Jun 2026.
When did Sonire Therapeutics last raise funding?
Sonire Therapeutics' most recent funding round on record is an undisclosed round of $13.0M, announced in Jun 2026.
Who founded Sonire Therapeutics?
FundedIQ lists Tohru Satoh (Founder) at Sonire Therapeutics.
Where is Sonire Therapeutics headquartered?
Sonire Therapeutics is based in Shinjuku, Yamanashi, Japan.
How many employees does Sonire Therapeutics have?
Sonire Therapeutics is in the 11-50 employee band.
How does Sonire Therapeutics' funding compare to other Biotechnology startups?
Sonire Therapeutics' latest round of $13.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Sonire Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sonire Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.